North Run Capital, LP Stereotaxis, Inc. Transaction History
North Run Capital, LP
- $43 Million
- Q4 2022
A detailed history of North Run Capital, LP transactions in Stereotaxis, Inc. stock. As of the latest transaction made, North Run Capital, LP holds 322,750 shares of STXS stock, worth $568,040. This represents 1.55% of its overall portfolio holdings.
Number of Shares
322,750
Previous 251,160
28.5%
Holding current value
$568,040
Previous $452,000
47.79%
% of portfolio
1.55%
Previous 0.92%
Shares
2 transactions
Others Institutions Holding STXS
# of Institutions
88Shares Held
41.6MCall Options Held
86.5KPut Options Held
43.2K-
Dafna Capital Management LLC Los Angeles, CA13.7MShares$24.1 Million8.6% of portfolio
-
Lagoda Investment Management, L.P. New York, NY3.83MShares$6.74 Million6.2% of portfolio
-
Redmile Group, LLC San Francisco, CA3.31MShares$5.82 Million0.34% of portfolio
-
Arbiter Partners Capital Management LLC New York, NY2.76MShares$4.85 Million11.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.61MShares$4.6 Million0.0% of portfolio
About Stereotaxis, Inc.
- Ticker STXS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,790,096
- Market Cap $132M
- Description
- Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...